{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:55:12Z","timestamp":1790016912650,"version":"4.0.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":988,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Otsuka"},{"name":"Boston Scientific"},{"name":"Eli Lilly Co."},{"name":"Daiichi Sankyo Inc."},{"name":"The Medicines Co."},{"name":"Portola"},{"name":"Accumetrics"},{"DOI":"10.13039\/100007110","name":"Schering-Plough","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004331","name":"Johnson & Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jacc.2010.04.063","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T04:28:17Z","timestamp":1289363297000},"page":"1683-1692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Antithrombotic Therapy in the Elderly"],"prefix":"10.1016","volume":"56","author":[{"given":"Davide","family":"Capodanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2010.04.063_bib1","first-page":"1","article-title":"Division of Vital Statistics. Deaths: final data for 2005. National vital statistics reports","volume":"56","author":"Kung","year":"2008","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.jacc.2010.04.063_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1377\/hlthaff.19.3.191","article-title":"Population aging: a comparison among industrialized countries","volume":"19","author":"Anderson","year":"2000","journal-title":"Health Aff"},{"key":"10.1016\/j.jacc.2010.04.063_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.critrevonc.2006.06.004","article-title":"Hemostasis and aging","volume":"60","author":"Franchini","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jacc.2010.04.063_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0002-9343(90)90525-I","article-title":"Platelet activity and phosphoinositide turnover increase with advancing age","volume":"88","author":"Bastyr","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cardiores.2004.12.027","article-title":"Endothelial aging","volume":"66","author":"Brandes","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2010.04.063_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/hh0801.089861","article-title":"Nitric oxide insufficiency, platelet activation, and arterial thrombosis","volume":"88","author":"Loscalzo","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.04.063_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-3848(80)90067-5","article-title":"Enhanced in vivo platelet \u201crelease reaction\u201d in old healthy individuals","volume":"17","author":"Zahavi","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2010.04.063_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jacc.2010.04.063_bib9","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2007.01.066","article-title":"Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative","volume":"49","author":"Skolnick","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1067\/mhj.2001.112404","article-title":"Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes","volume":"141","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.04.063_bib11","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2010.04.063_bib12","first-page":"408","article-title":"Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease","volume":"85","author":"Nascitz","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacc.2010.04.063_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0002-9343(03)00436-4","article-title":"Early and late effects of low-dose aspirin on renal function in elderly patients","volume":"115","author":"Segal","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-150-6-200903170-00009","article-title":"Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force","volume":"150","author":"Wolff","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2010.04.063_bib17","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","article-title":"Aspirin dose for the prevention of cardiovascular disease: a systematic review","volume":"297","author":"Campbell","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2010.04.063_bib18","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jacc.2007.08.002","volume":"50","author":"Fraker","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib20","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","volume":"54","author":"Kushner","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib21","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.CIR.101.10.1097","article-title":"Aspirin use is low among United States outpatients with coronary artery disease","volume":"101","author":"Stafford","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib22","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2006.04.026","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.04.063_bib26","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.0000029926.71825.E2","article-title":"Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups","volume":"106","author":"Budaj","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib29","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/01.CIR.0000142862.98817.1F","article-title":"Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial","volume":"110","author":"Guagliumi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib30","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1161\/CIRCULATIONAHA.106.642306","article-title":"Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions","volume":"114","author":"Ndrepea","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-8703(00)90018-8","article-title":"Age and outcome after acute coronary syndromes without persistent ST-segment elevation","volume":"139","author":"Hasdai","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.04.063_bib32","first-page":"2037","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo controlled trial (published correction appears in Lancet 2001;357:1370)","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.04.063_bib33","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib34","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.04.063_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Low-molecular-weight heparin during instability in coronary artery disease","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.04.063_bib37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0735-1097(98)00022-9","article-title":"Use and effectiveness of intravenous heparin therapy for treatment of acute myocardial infarction in the elderly","volume":"31","author":"Krumholz","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.292.1.55","article-title":"Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial","volume":"292","author":"Blazing","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2010.04.063_bib39","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/eurheartj\/ehn236","article-title":"Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial","volume":"29","author":"Lopes","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.04.063_bib40","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2008.12.021","article-title":"Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial","volume":"53","author":"Lopes","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1540-8183.2008.00422.x","article-title":"Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention","volume":"22","author":"Lemesle","year":"2009","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002512-200724060-00005","article-title":"Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients","volume":"24","author":"Bartholomew","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jacc.2010.04.063_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11239-006-9019-2","article-title":"Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia","volume":"22","author":"Guzzi","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2010.04.063_bib44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-147-5-200709040-00005","article-title":"Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes","volume":"147","author":"Fox","year":"2007","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.1016\/j.jacc.2010.04.063_bib46","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1378\/chest.08-0693","article-title":"Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2010.04.063_bib47","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ahj.2008.06.029","article-title":"Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis","volume":"156","author":"Goto","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.04.063_bib48","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2010.04.063_bib49","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2010.04.063_bib50","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hyleck","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjmed.2005.02.022","article-title":"Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall","volume":"118","author":"Gage","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archinte.1996.00440040081009","article-title":"Bleeding during antithrombotic therapy in patients with atrial fibrillation","volume":"156","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0749-0690(05)70105-1","article-title":"Hemorrhagic complications of oral anticoagulant therapy","volume":"17","author":"Beyth","year":"2001","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.04.063_bib55","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1378\/chest.127.6.2049","article-title":"Warfarin maintenance dosing patterns in clinical practice","volume":"127","author":"Garcia","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2010.04.063_bib56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ageing\/20.3.217","article-title":"The association of age with dosage requirement for warfarin","volume":"20","author":"Redwood","year":"1991","journal-title":"Age Ageing"},{"key":"10.1016\/j.jacc.2010.04.063_bib57","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-116-11-901","article-title":"Aging and the anticoagulant response to warfarin therapy","volume":"116","author":"Gurwitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","article-title":"Estimation of the warfarin dose with clinical and pharmacogenetic data","volume":"360","author":"Klein","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib59","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1592\/phco.20.11.923.35260","article-title":"Evaluation of warfarin initiation regimens in elderly patients","volume":"20","author":"O'Connell","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2010.04.063_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1008884004751","article-title":"Long-term anticoagulation therapy for atrial fibrillation in elderly patients: efficacy, risk, and current patterns of use","volume":"7","author":"McCormick","year":"1999","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2010.04.063_bib61","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jacc.2009.04.084","article-title":"Pharmacogenetics in cardiovascular antithrombotic therapy","volume":"54","author":"Mar\u00edn","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.159.5.457","article-title":"Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism","volume":"159","author":"Kuijer","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib64","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1378\/chest.130.5.1390","article-title":"Development of a contemporary bleeding risk model for elderly warfarin recipients","volume":"130","author":"Shireman","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2010.04.063_bib65","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.04.063_bib66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1540-8183.2005.04065.x","article-title":"Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction","volume":"18","author":"Mattichack","year":"2005","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib67","first-page":"162","article-title":"Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding","volume":"18","author":"Khurram","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib68","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinte.165.7.784","article-title":"Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction","volume":"165","author":"Buresly","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib69","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","article-title":"Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.04.063_bib71","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.94.8.1826","article-title":"Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trial: Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries Trial","volume":"94","author":"White","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib72","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0735-1097(94)00367-Y","article-title":"Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial","volume":"25","author":"Stone","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib73","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199706053362301","article-title":"A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib74","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib75","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/CIRCULATIONAHA.105.558676","article-title":"Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty","volume":"112","author":"Thune","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.04.063_bib76","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.04.063_bib77","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.04.063_bib78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amjcard.2004.04.019","article-title":"Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)","volume":"94","author":"Curtis","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2010.04.063_bib79","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/eurheartj\/ehm081","article-title":"Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25","volume":"28","author":"White","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.04.063_bib80","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ehj.2003.07.004","article-title":"Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb\/IIIa inhibitor therapy in acute myocardial infarction: dichotomous response as a function of age in the GUSTO V trial","volume":"24","author":"Savonitto","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.04.063_bib81","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1503\/cmaj.051410","article-title":"Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data","volume":"174","author":"Armstrong","year":"2006","journal-title":"CMAJ"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971003812X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971003812X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:40:27Z","timestamp":1760013627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971003812X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":81,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S073510971003812X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2010.04.063","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy in the Elderly","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2010.04.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}